277 related articles for article (PubMed ID: 19286886)
1. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
Goldin LR; Björkholm M; Kristinsson SY; Turesson I; Landgren O
Haematologica; 2009 May; 94(5):647-53. PubMed ID: 19286886
[TBL] [Abstract][Full Text] [Related]
2. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
[TBL] [Abstract][Full Text] [Related]
3. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
4. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.
Goldin LR; Landgren O; McMaster ML; Gridley G; Hemminki K; Li X; Mellemkjaer L; Olsen JH; Linet MS
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2402-6. PubMed ID: 16214923
[TBL] [Abstract][Full Text] [Related]
5. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.
Landgren O; Kristinsson SY; Goldin LR; Caporaso NE; Blimark C; Mellqvist UH; Wahlin A; Bjorkholm M; Turesson I
Blood; 2009 Jul; 114(4):791-5. PubMed ID: 19182202
[TBL] [Abstract][Full Text] [Related]
6. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.
Goldin LR; Pfeiffer RM; Li X; Hemminki K
Blood; 2004 Sep; 104(6):1850-4. PubMed ID: 15161669
[TBL] [Abstract][Full Text] [Related]
7. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
8. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
9. Survival patterns among lymphoma patients with a family history of lymphoma.
Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
[TBL] [Abstract][Full Text] [Related]
10. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.
Cerhan JR; Janney CA; Vachon CM; Habermann TM; Kay NE; Potter JD; Sellers TA; Folsom AR
Am J Epidemiol; 2002 Sep; 156(6):527-35. PubMed ID: 12226000
[TBL] [Abstract][Full Text] [Related]
11. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
Altieri A; Bermejo JL; Hemminki K
Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
[TBL] [Abstract][Full Text] [Related]
12. Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia.
Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
Eur J Haematol; 2020 Dec; 105(6):779-785. PubMed ID: 32871627
[TBL] [Abstract][Full Text] [Related]
13. Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms.
Altieri A; Bermejo JL; Hemminki K
Leukemia; 2005 Dec; 19(12):2342-3. PubMed ID: 16224483
[No Abstract] [Full Text] [Related]
14. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.
Cerhan JR; Wallace RB; Dick F; Kemp J; Parker AS; Zheng W; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):361-8. PubMed ID: 11319177
[TBL] [Abstract][Full Text] [Related]
15. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
16. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
17. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract][Full Text] [Related]
18. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma.
Pottern LM; Linet M; Blair A; Dick F; Burmeister LF; Gibson R; Schuman LM; Fraumeni JF
Leuk Res; 1991; 15(5):305-14. PubMed ID: 2046383
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
Nie G; Sun L; Zhang C; Yuan Y; Mao H; Wang Z; Li J; Duan S; Xing C; Zhang B
Front Immunol; 2022; 13():903315. PubMed ID: 36172352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
